title: Botox, migraine, and the American Academy of Neurology: an antidote to anecdote.
authors.affiliation: Green Shield Canada, 8677 Anchor Dr., P.O. Box 1606, Windsor, Ontario N9A 6W1 Canada. Mark.jackson@greenshield
authors.forename: Mark
authors.initials: M
authors.lastname: Jackson
authors.forename: John P
authors.initials: JP
authors.lastname: Barbuto
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012955:Societies, Medical; D017211:Treatment Failure; D014481:United States
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A